Evaluation of Silymarin for management of anti-tuberculosis drug induced liver injury: a randomized clinical trial

AIM: This study was performed to evaluate the potential efficacy of silymarin in the management of anti-tuberculosis medication’s induced liver injury. BACKGROUND: Hepatic toxicity is the most serious complication in treatment of tuberculosis. METHODS: In a randomized double blind clinical trial (AC...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Gastroenterol Hepatol Bed Bench
Autors principals: Marjani, Majid, Fahim, Fanak, Sadr, Makan, Kazempour Dizaji, Mehdi, Moniri, Afshin, Khabiri, Shadi, Tabarsi, Payam, Velayati, Ali Akbar
Format: Artigo
Idioma:Inglês
Publicat: Shaheed Beheshti University of Medical Sciences 2019
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6536020/
https://ncbi.nlm.nih.gov/pubmed/31191838
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars